Review Open Access
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Urol. Jul 24, 2014; 3(2): 81-86
Published online Jul 24, 2014. doi: 10.5410/wjcu.v3.i2.81
Kidney stones over 2 cm in diameter-between guidelines and individual approach
Piotr Bryniarski, Marcin Zyczkowski, Piotr Taborowski, Andrzej Paradysz, Department of Urology, Medical University of Silesia in Katowice, Zabrze 41-800, Silesia, Poland
Arkadiusz Miernik, Martin Schoenthaler, Department of Urology, University Medical Centre, 79106 Freiburg, Germany
Author contributions: All authors contributed equally to this work.
Correspondence to: Piotr Bryniarski, PhD, Department of Urology, Medical University of Silesia in Katowice, 3 Maja Street 13-15, Zabrze 41-800, Silesia, Poland. piotr.bryniarski@hotmail.com
Telephone: +48-32-23704454 Fax: +48-32-23704454
Received: March 12, 2014
Revised: April 25, 2014
Accepted: May 29, 2014
Published online: July 24, 2014
Processing time: 129 Days and 21.3 Hours

Abstract

The prevalence of urolithiasis has been observed to increase during last decades. Kidney stones over 2 cm in diameter are the common urologic problem. European and American Associations of Urology has published guidelines on Urolithiasis and presented the most effective tools to treat large stones. On the other hand many experienced endourologic centres choose other modalities from their armamentarium. All treatment methods are characterized by their efficacy and safety which are usually inversely proportional. It is crucial for patients and physicians to find a golden mean. Percutaneous lithotripsy is still considered treatment of choice with more than 95% efficacy. Less invasive retrograde intrarenal surgery is also less effective, but burdened with lower complication rate. Extracorporeal shockwave lithotripsy is feasible in paediatric patients with acceptable stone free rates. Open surgery (pylolithotomy and anatrophic nephrolithotomy) are almost obsolete techniques. All methods have their pros and cons. Physicians should share decisions regarding treatment modalities with patients.

Key Words: Kidney stones; Percutaneous lithotripsy; Shockwave lithotripsy; Retrograde intrarenal surgery; Pylolithotomy; Anatrophic lithotomy

Core tip: There are various modalities for treatment of kidney stones over 2 cm in diameter. Guidelines indicate the most appropriate methods. Percutaneous lithotripsy is considered first line treatment while retrograde intrarenal surgery or shockwave lithotripsy are optional approaches. Apart from guidelines physicians should share decisions regarding optimal treatment with patients.



INTRODUCTION

Nephrolithiasis is one of the most common diseases afflicting mankind. It has been reported in various medical writings since antiquity. In United States its prevalence has doubled since the sixties being now between 2% and 7%. Similarly in countries of Western Europe like Germany, Spain and Italy its prevalence has also been rising[1,2]. It has recently been shown that the real prevalence might even be higher reaching 8.4%. Men are afflicted more frequently than women (10.6% vs 7.1%). Racial differences are evident. The most commonly afflicted are white males. African-American females develop least likely urinary stones, while other races are in-between[3].

Urolithiasis manifest itself clinically mostly between 30 and 50 years of patients’ age. The risk of recurrent renal colic after the first stone episode is roughly 15% during the first 3 years and grows up to 50% for the next 7 years[4,5]. In patients with more than one stone diagnosed during their first renal colic this ratio might increase to 75%. After every urolithiasis treatment, the patients should be stratified and accordingly assign to low or high risk group of stone recurrence. Urolithiasis promoting factors as patients’ age, recurrent stone formers, familial urolithiasis, calcium hydrogenphosphate (brushite), uric acid, cystine, and so called infection stones have to be analysed and appropriately considered for the further management. This group requires thorough metabolic evaluation and a close follow-up. However, only in 20% of the patients a systemic disease predisposing to stone formation can be identified[6].

Over the last centuries a significant shift in stone location has been observed from the lower to the upper urinary tract. A disease considered previously as male ailment is now gender blind. Metabolic diseases such as obesity and diabetes are strongly associated with urolithiasis. It seems that diet and lifestyle play an important role in disease development[7]. Nephrolithiasis might be an effect of other systemic diseases such as: inherited and acquired renal tubular acidosis, primary and secondary hyperparathyroidism, gout, various neoplasms, primary hyperoxaluria, gastrointestinal diseases, sarcoidosis, recurrent/persistent urinary tract infection, metabolic syndrome and cystinuria. Some anatomical abnormalities of the urinary tract are also associated with lithogenesis and comprise: horseshoe kidney, ureteropelvic junction obstruction, medullary sponge kidney, calyceal diverticulum and vesicoureteral reflux[8]. Urinary tract infections play an important role in stone formation and thus need a special clinical attention and management. As it can be seen in the example of staghorn calculi, most of them have an infectious origin and consist of magnesium ammonium phosphate-struvite or carbonate apatite- dahlite or ammonium urate[9,10].

The aim of our study was to present and compare several treatment methods that can be offered for patients with renal stones over 2 cm in diameter.

Medline was search for articles published between 1977 and 2013. The following keywords were entered: “kidney stone”, “Percutaneous nephrolithotripsy”, “extracorporeal shockwave lithotripsy” and “retrograde intrarenal surgery”. Only English written papers were included. Only papers most relevant for the purpose of this review were included.

DO WE HAVE TO TREAT KIDNEY STONES?

Until now this crucial question remains at least partially unanswered. What is the appropriate clinical management for small asymptomatic calyceal stones, that do not grow? For all other renal stones active treatment is recommended. Referring to this, Guidelines on Urolithiasis of the European Association of Urology changed in 2011. Previously, active stone removal had only been recommended for calculi > 6 mm. In accordance to the literature, a rate of spontaneous passage was estimated to be 1% in comparison to smaller stones (i.e., < 3 mm) when almost all stones can be expelled[11]. Currently guidelines state that all stones over 15 mm in diameter should be removed. This recommendation is based on a trial revealing, that there are no differences between active and conservative approach in asymptomatic calyceal kidney stones < 15 mm in diameter in terms of stone free rate, symptoms, quality of life and renal function[12]. Therefore patients who elect observation instead of active treatment of their kidney stones should be informed about the possible course of the disease. In that situation, in three years 77% of asymptomatic patients with kidney calculi will progress and 26% will require active treatment. Moreover, lower pole stones grow more frequently than middle and upper pole stones (61% vs 47%). The rate of growth is positively correlated with uric acid concentration in serum and urine[13]. Therefore individual approach for each patient is advised with abovementioned consideration and taking into account other clinical information obtained from patients history (e.g., occupation, etc.). For that reason, even small asymptomatic calyceal stones should be actively treated in jet pilots, travelers, etc.

There is no such question in terms of larger stones. Staghorn calculi inevitably lead to unresolved/persistent urinary tract infections with loss of renal parenchyma, chronic pylonephritis and eventually loss of kidney function[9,14-17]. Untreated large stones may also cause life-threatening urosepsis which in some circumstances requires intensive care management or even nephrectomy.

METHODS OF TREATMENT

Renal stone treatment has gone through significant changes over last decades from mainly open surgeries to minimally invasive ones. The treatment modality depends mainly on stone size, hardness and position within the kidney. The last Guidelines on Urolithiasis of the European Association of Urology (EAU) recommend endourology as a treatment option for renal calculi over 20 mm in diameter stating simultaneously superiority of percutaneous lithotripsy (PNL)[8]. However, optional approaches in large stones are feasible and comprise retrograde intrarenal surgery (RIRS) with flexible(fRIRS) or semirigid ureterorenoscopes (rRIRS), endoscopic combined intrarenal surgery (ECIRS), shockwave lithotripsy (SWL) and exceptionally open surgery (pylolithotomy and anatrophic nephrolithotomy).

PNL and open surgery

Until the last year, PNL had been the gold standard in the treatment of renal stones over 2 cm in diameter. Still this technique is being chosen among other methods as first line therapy for large renal calculi. It remains also an alternative for smaller stones formed by cystine, brushite and whewellite which are usually very hard and associated with lower stone free rates when treated with different modalities. It was shown that stone density over 970 Hounsfield units on non-contrast computed tomography are efficiently destructed by SWL in 38% in comparison with softer stones where such ratio reached 96%[18]. Usually 3-5 ineffective sessions with SWL also should prompt physician to offer more invasive methods to the patient.

There are many different PNL techniques. None appears to be more efficient than the others. The procedure can be conducted in prone and supine position. Originally PNL was described in prone position with specially invented metal dilators[19]. This kind of patient positioning offers an unlimited access to the kidney even in terms of a multi-track approach. Subsequently supine position was proposed by Valdivia Uría et al[20] to improve direct anesthesiological access to the patient’s chest and to minimize the vena cava-syndrome. A further miniaturization of the equipment allowed to perform PNLs in children[21,22]. As standard PNL procedures are performed with 28-Fr or 30-Fr channel mini PNL offers smaller sheaths between 12-Fr and 20-Fr. Unfortunately ultrasonic disintegration is technically unfeasible in these systems. The next step of miniaturization called ultra-mini-PNL (UMP) has been shortly presented[23]. The procedure is carried out using a 3.5-F telescope and special inner and outer sheaths. After puncturing the kidney, tract dilatation up to 13-F is performed. Stones are disintegrated with a 365-μ holmium laser fibre and actively evacuated by creating an eddy current of saline in the instrument shaft. Further miniaturization has allowed to disintegrate stones with the so called “all-seeing needle” (4.8-Fr). Using this, micro PNL device, renal stones can be disintegrated but neither actively extracted nor washed out. Concerning the size of the instrument, it can be excellently used in paediatric urology[24,25].

To make PNL more convenient for patients tubeless (without nephrostomy) and totally tubeless (without nephrostomy and ureteral catheter) variations of procedure were proposed. Conventional PNL comprise insertion of nephrostomy tube after completion of surgery. This allows free drainage of clots and remnant stones as well acts as hemostat when closed for a short period after procedure. However, hospitalization and operation times are significantly longer in comparison with tubeless procedures[26-29].

Over the last three decades PNL has supplanted pylolithotomy and anatrophic nephrolithotomy in treatment of larger stones mostly due to its significantly decreased invasiveness with only marginally worse efficacy. The last comparison between open stone surgery and percutaneous nephrolithotomy was performed in the late 90’s and showed that pyelolithotomy or nephrolitotomy was superior in terms of SFRs[30,31]. Despite inferior SFRs, PNL replaced open surgery in treatment of large kidney calculi. The reason for that might have been the acceptance of SFRs in favour of lower complication rate during PNL compared to the open approach. Due to continuous increase of expertise in PNL, both methods seem to have similar efficacy (see Table 1). Another endoscopic alternative in treatment of large renal stones might be a laparoscopic approach. As a minimally invasive procedure, PNL similar SFRs burdened with longer operative times were documented[32]. It is worth emphasizing that PNL is not free from complications. The most common are infections occurring in up to 35% of patients. Significant bleeding at 7.8% and mortality rates at up to 0.5% were estimated[33,34].

Table 1 The summary of procedures feasible in treatment of renal stones over 2 cm in diameter.
Stone free rate2Complications rate3Ancillary proceduresOperating room time, min
Open surgery[30,31]171%-84%46%-130
PNL[26-29,32,34]75%-98%0%-33%9%-33%52
ESWL[42-47]45%-60%–adults6%18%50-70
85%–children
fRIRS[50,51-56]90%8%-10%3%-13%82-94
rRIRS[50,54]Aug-81%8%-15%12%-5%85-98
Shockwave lithotripsy for large renal stones

In 1984 first SWL machine was introduced for the treatment of kidney stones. Dornier Human Model 1 was a prototype while model number 3 was the first generation lithotripter that was widely used in the clinic[35,36]. First interventions were performed under general anaesthesia. The patient was positioned in a large basin filled with degassed fluid. Until now HM-3 Dornier has had the highest known efficacy throughout all shockwave lithotripters.

The mechanism of stone fragmentation is based on a rule that focused ultrasound waves can cause hard object disintegration through tear forces, spalliation, cavitation and squeezing[35,37-41].

With only 45%-60% stone free rate SWL efficacy in kidney stones over 2 cm in diameter may be consider as disappointing[42,43]. In older studies SFRs up to 70% with low complications rate were reported[44]. Fortunately, significantly higher SFRs reaching 85% can be achieved in paediatric patients[45-47]. In comparison PNL in children shows the same treatment efficacy as in adults. PNL stone free rates in this group ranges from 68% to 100%[48,49].

In conclusion SWL in patients with stones over 20 mm in diameter is inappropriate except paediatric patients, where an individual approach should always be aimed.

RIRS

Continuously mastered lithotripsy through natural body orifices (as ureteroscopy) has nowadays allowed to achieve satisfactory results with low complication rates. Although lower SFRs in comparison to PNL, natural orifice transluminal endoscopic surgery (NOTES) is characterized by low morbidity rates, pain and hospitalization times[50]. RIRS may be done using flexible (fRIRS) and semirigid instruments (rRIRS). Flexible ureterorenoscopy is characterized by a small shaft calibre, usually less than 10-F. In stones over 2 cm prolonged operation times can be observed (mean 82.5 max up to 215 min). Excellent SFRs above 90% are reported in centres with profound experience in urinary stone management and high case load. It was shown that 1.6 procedures per patient are needed to achieve superior results in terms of RIRS treatment[51,52]. Complication rates were calculated to occur in 10% of patients while major complications contribute approximately to half of them[53]. Instrument costs for flexible ureterorenoscopy are high and appear to be a limiting factor. Due to a very fragile laser fibres which is frequently bent within the working channel of the instrument, its breakage and a consecutive damage of the scope might occur. On contrary, the latest comparison of costs between PNL and fRIRS revealed a vast economic advantage towards ureteroscopy ($ 19845 vs $ 6675) at least in the United States health care system[53].

The main disadvantages of NOTES-based techniques using semirigid ureterorenoscopes in comparison to fRIRS is their inability to disintegrate stones in lower and middle calyces, potentially high renal fluid pressure, limited intraoperative manoeuvrability and occasional inability to pass the scope through a tight ureter. The main advantage is the ability to pass stone extraction devices through wide working channels and high irrigation flow significantly improving visibility. In the last years we observe many efforts to increase the disintegration rate while lowering the morbidity[54,55]. However, even with this improvements reported SFRs are lower in comparison to fRIRS (90% vs 81.8%)[50,51,53,54,56]. On the other hand the number of ancillary procedures is inferior for rRIRS (see Table 1)[51]. The costs for rRIRS are lower than for fRIRS strongly depending on scope damages during procedure.

One of the most important questions regarding urolithiasis therapy has still to be answered. “Can we achieve high stone free rates with low morbidity only in experienced institutions specialized in urinary stone treatment or is it also feasible for all centres”.

HOW TO ASSESS TREATMENT SUCESS?

The answer seems to be simple at first sight–lack of stones after the procedure. In most cases stone free status is estimated on the basis of ultrasound and X-ray, rarely on computed tomography (CT). It was shown that results documented by CT and ultrasound + X-ray may tremendously differ (62.3% vs 20.8%) in the same treatment group[57]. Noncontrast enhanced computer tomography (NCCT) has become a new diagnostic standard for evaluation of acute flank pain. Its sensitivity for identifying urinary stones was estimated by 96%[58]. Sensitivity of ultrasound for identifying renal stones over 5 mm is also 96%[59]. X-ray is used mainly due to its high specificity (80%-87%) in detection of urolithiasis[60]. Taking into consideration the abovementioned facts one may think that X-ray and ultrasound could be equal to CT in identifying significant residual stones (> 4 mm). Indeed this is not true. Park et al[57] in their study shown that almost 50% of stones over 4 mm in diameter are visible on NCCT and are not visualized on X-ray (mean size 7.4 mm). These facts strongly support the need for performing NCCT to assess residual stones after lithotripsy. It is also very difficult to compare the results of studies where other than NCCT diagnostic methods of efficacy were applied.

The definitions of stone SFRs are various. Some authors conservatively consider a stone free status as a renal pelvis free of any remaining fragments. Some are more liberal and treat insignificant stones as no stones at all. That concept of insignificant stone is based on statistics which states that almost all stones < 3 mm are freely expellable. On the other hand, some date suggest, that even small persistent calculi might accelerate stone formation and significantly shorten recurrence free intervals.

At last, appropriate scheduling for postoperative evaluation and imaging is crucial. It was shown that up to 25% of patients may become stone free when assessed 1 mo postoperatively in comparison to a group examined one day after a rRIRS intervention[50].

WHICH TECHNIQUE SHOULD BE CHOSEN FOR KIDNEY STONES OVER 2 CM?

The last EAU guidelines on urolithiasis recommend endourology for the treatment of > 2 cm renal calculi[8,9]. Nowadays, a wide spectrum of procedures and therapeutic modalities is available and allows the surgeon to offer an individualized treatment strategy to the patients taking into account all relevant clinical and patient-related parameters. The patient should also be well informed about advantages and disadvantages of each option and be involved in the decision making process. While many patients choose PNL as widely established standard for treatment of a > 2 cm kidney stone, others may benefit from less invasive procedures accepting lower efficacy and necessity for ancillary procedures. The summary of abovementioned procedures is given in Table 1.

Footnotes

P- Reviewers: Shrestha BM, Wang XH S- Editor: Ji FF L- Editor: A E- Editor: Lu YJ

References
1.  Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86-e96.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Lieske JC, Peña de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69:760-764.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 178]  [Cited by in F6Publishing: 167]  [Article Influence: 9.3]  [Reference Citation Analysis (0)]
3.  Sakhaee K, Maalouf NM, Sinnott B. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012;97:1847-1860.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 144]  [Cited by in F6Publishing: 151]  [Article Influence: 12.6]  [Reference Citation Analysis (0)]
4.  Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111:1006-1009.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 221]  [Cited by in F6Publishing: 215]  [Article Influence: 6.1]  [Reference Citation Analysis (0)]
5.  Ahlstrand C, Tiselius HG. Recurrences during a 10-year follow-up after first renal stone episode. Urol Res. 1990;18:397-399.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 50]  [Cited by in F6Publishing: 51]  [Article Influence: 1.5]  [Reference Citation Analysis (1)]
6.  Strauss AL, Coe FL, Parks JH. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982;142:504-507.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 24]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
7.  Scales CD, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160-165.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1738]  [Cited by in F6Publishing: 1599]  [Article Influence: 133.3]  [Reference Citation Analysis (0)]
8.  Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C. Guidelines on urolithiasis. European Association of Urology Web site.  Available from: http: //www.uroweb.org/fileadmin/user_upload/Guidelines/Urolithiasis.pdf.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Preminger GM, Assimos DG, Lingerman JE, Nakada SY, Pearle MS, Wolf JS. Report on the Management of Staghorn Calculi (2005).  Available from: http: //www.auanet.org/education/guidelines/staghorn-calculi.cfm.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Bruce RR, Griffith DP. Retrospective follow-up of patients with struvite calculi. Urolithiasis Clinical and Basic Research. New York: Plenum Press 1981; 191.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 6]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
11.  Masarani M, Dinneen M. Ureteric colic: new trends in diagnosis and treatment. Postgrad Med J. 2007;83:469-472.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 27]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
12.  Keeley FX Jr, Tilling K, Elves A, Menezes P, Wills M, Rao N, Feneley R. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. BJU Int. 2001;87:1-8.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 81]  [Cited by in F6Publishing: 72]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
13.  Burgher A, Beman M, Holtzman JL, Monga M. Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. J Endourol. 2004;18:534-539.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 118]  [Cited by in F6Publishing: 105]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
14.  Rous SN, Turner WR. Retrospective study of 95 patients with staghorn calculus disease. J Urol. 1977;118:902-904.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Koga S, Arakaki Y, Matsuoka M, Ohyama C. Staghorn calculi--long-term results of management. Br J Urol. 1991;68:122-124.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 89]  [Cited by in F6Publishing: 95]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
16.  Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M, Alberta Kidney Disease Network. Kidney stones and kidney function loss: a cohort study. BMJ. 2012;345:e5287.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 190]  [Cited by in F6Publishing: 224]  [Article Influence: 18.7]  [Reference Citation Analysis (0)]
17.  El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ, Krambeck AE, Rule AD. Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol. 2012;7:1409-1415.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 82]  [Cited by in F6Publishing: 95]  [Article Influence: 7.9]  [Reference Citation Analysis (0)]
18.  Ouzaid I, Al-qahtani S, Dominique S, Hupertan V, Fernandez P, Hermieu JF, Delmas V, Ravery V. A 970 Hounsfield units (HU) threshold of kidney stone density on non-contrast computed tomography (NCCT) improves patients’ selection for extracorporeal shockwave lithotripsy (ESWL): evidence from a prospective study. BJU Int. 2012;110:E438-E442.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 92]  [Cited by in F6Publishing: 101]  [Article Influence: 8.4]  [Reference Citation Analysis (0)]
19.  Alken P, Hutschenreiter G, Günther R, Marberger M. Percutaneous stone manipulation. J Urol. 1981;125:463-466.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Valdivia Uría JG, Valle Gerhold J, López López JA, Villarroya Rodriguez S, Ambroj Navarro C, Ramirez Fabián M, Rodriguez Bazalo JM, Sánchez Elipe MA. Technique and complications of percutaneous nephroscopy: experience with 557 patients in the supine position. J Urol. 1998;160:1975-1978.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 170]  [Cited by in F6Publishing: 201]  [Article Influence: 7.7]  [Reference Citation Analysis (0)]
21.  Jackman SV, Hedican SP, Peters CA, Docimo SG. Percutaneous nephrolithotomy in infants and preschool age children: experience with a new technique. Urology. 1998;52:697-701.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 264]  [Cited by in F6Publishing: 239]  [Article Influence: 9.2]  [Reference Citation Analysis (0)]
22.  Jackman SV, Docimo SG, Cadeddu JA, Bishoff JT, Kavoussi LR, Jarrett TW. The “mini-perc” technique: a less invasive alternative to percutaneous nephrolithotomy. World J Urol. 1998;16:371-374.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 257]  [Cited by in F6Publishing: 275]  [Article Influence: 10.6]  [Reference Citation Analysis (0)]
23.  Desai J, Solanki R. Ultra-mini percutaneous nephrolithotomy (UMP): one more armamentarium. BJU Int. 2013;112:1046-1049.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 46]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
24.  Armagan A, Tepeler A, Silay MS, Ersoz C, Akcay M, Akman T, Erdem MR, Onol SY. Micropercutaneous nephrolithotomy in the treatment of moderate-size renal calculi. J Endourol. 2013;27:177-181.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 51]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
25.  Kaynar M, Sümer A, Şalvarcı A, Tekinarslan E, Cenker A, Istanbulluoğlu MO. Micropercutaneous nephrolithotomy (microperc) in a two-year-old with the ‘all-seeing needle’. Urol Int. 2013;91:239-41.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 14]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
26.  Borges CF, Fregonesi A, Silva DC, Sasse AD. Systematic Review and Meta-Analysis of Nephrostomy Placement Versus Tubeless Percutaneous Nephrolithotomy. J Endourol. 2010;Oct 19; Epub ahead of print.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 27]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
27.  Zilberman DE, Lipkin ME, de la Rosette JJ, Ferrandino MN, Mamoulakis C, Laguna MP, Preminger GM. Tubeless percutaneous nephrolithotomy--the new standard of care? J Urol. 2010;184:1261-1266.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 63]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
28.  Karami H, Gholamrezaie HR. Totally tubeless percutaneous nephrolithotomy in selected patients. J Endourol. 2004;18:475-476.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 82]  [Cited by in F6Publishing: 93]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
29.  Karami H, Jabbari M, Arbab AH. Tubeless percutaneous nephrolithotomy: 5 years of experience in 201 patients. J Endourol. 2007;21:1411-1413.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 20]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
30.  Charig CR, Webb DR, Payne SR, Wickham JE. Comparison of treatment of renal calculi by open surgery, percutaneous nephrolithotomy, and extracorporeal shockwave lithotripsy. Br Med J (Clin Res Ed). 1986;292:879–882.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 103]  [Cited by in F6Publishing: 125]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
31.  Assimos DG, Wrenn JJ, Harrison LH, McCullough DL, Boyce WH, Taylor CL, Zagoria RJ, Dyer RB. A comparison of anatrophic nephrolithotomy and percutaneous nephrolithotomy with and without extracorporeal shock wave lithotripsy for management of patients with staghorn calculi. J Urol. 1991;145:710-714.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Haggag YM, Morsy G, Badr MM, Al Emam AB, Farid M, Etafy M. Comparative study of laparoscopic pyelolithotomy versus percutaneous nephrolithotomy in the management of large renal pelvic stones. Can Urol Assoc J. 2013;7:E171-E175.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 17]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
33.  Osman M, Wendt-Nordahl G, Heger K, Michel MS, Alken P, Knoll T. Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int. 2005;96:875-878.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 190]  [Cited by in F6Publishing: 180]  [Article Influence: 9.5]  [Reference Citation Analysis (0)]
34.  de la Rosette J, Assimos D, Desai M, Gutierrez J, Lingeman J, Scarpa R, Tefekli A; CROES PCNL Study GroupJ Endourol. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol. 2011;25:11-7.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 482]  [Cited by in F6Publishing: 493]  [Article Influence: 37.9]  [Reference Citation Analysis (1)]
35.  Chaussy C, Brendel W, Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet. 1980;2:1265-1268.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 826]  [Cited by in F6Publishing: 692]  [Article Influence: 15.7]  [Reference Citation Analysis (0)]
36.  Lingeman JE, Newman D, Mertz JH, Mosbaugh PG, Steele RE, Kahnoski RJ, Coury TA, Woods JR. Extracorporeal shock wave lithotripsy: the Methodist Hospital of Indiana experience. J Urol. 1986;135:1134-1137.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Crum LA. Cavitation microjets as a contributory mechanism for renal calculi disintegration in ESWL. J Urol. 1988;140:1587-1590.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Zhong P, Xi X, Zhu S, Cocks FH, Preminger GM. Recent developments in SWL physics research. J Endourol. 1999;13:611-617.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 37]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
39.  Eisenmenger W. The mechanisms of stone fragmentation in ESWL. Ultrasound Med Biol. 2001;27:683-693.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 161]  [Cited by in F6Publishing: 101]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
40.  Sapozhnikov OA, Maxwell AD, MacConaghy B, Bailey MR. A mechanistic analysis of stone fracture in lithotripsy. J Acoust Soc Am. 2007;121:1190-1202.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 117]  [Cited by in F6Publishing: 51]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
41.  Maxwell AD, Wang TY, Cain CA, Fowlkes JB, Sapozhnikov OA, Bailey MR, Xu Z. Cavitation clouds created by shock scattering from bubbles during histotripsy. J Acoust Soc Am. 2011;130:1888-1898.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 212]  [Cited by in F6Publishing: 164]  [Article Influence: 12.6]  [Reference Citation Analysis (0)]
42.  Al-Ansari A, As-Sadiq K, Al-Said S, Younis N, Jaleel OA, Shokeir AA. Prognostic factors of success of extracorporeal shock wave lithotripsy (ESWL) in the treatment of renal stones. Int Urol Nephrol. 2006;38:63-67.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 38]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
43.  El-Assmy A, El-Nahas AR, Madbouly K, Abdel-Khalek M, Abo-Elghar ME, Sheir KZ. Extracorporeal shock-wave lithotripsy monotherapy of partial staghorn calculi. Prognostic factors and long-term results. Scand J Urol Nephrol. 2006;40:320-325.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 10]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
44.  Yamaguchi A. Extracorporeal shock wave lithotripsy monotherapy for staghorn calculi. Eur Urol. 1994;25:110-115.  [PubMed]  [DOI]  [Cited in This Article: ]
45.  Shouman AM, Ziada AM, Ghoneim IA, Morsi HA. Extracorporeal shock wave lithotripsy monotherapy for renal stones >25 mm in children. Urology. 2009;74:109-111.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 42]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
46.  Orsola A, Diaz I, Caffaratti J, Izquierdo F, Alberola J, Garat JM. Staghorn calculi in children: treatment with monotherapy extracorporeal shock wave lithotripsy. J Urol. 1999;162:1229-1233.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 40]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
47.  Mohamad Al-Ali B, Pummer K. Large stone clearance in 2-year-old child with staghorn and calyceal stones using SWL monotherapy. Cent European J Urol. 2012;65:28-29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
48.  Desai M. Endoscopic management of stones in children. Curr Opin Urol. 2005;15:107-112.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 39]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
49.  Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Hussain M, Zafar MN, Sultan S, Mehdi H. Management of pediatric urolithiasis in Pakistan: experience with 1,440 children. J Urol. 2003;169:634-637.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 5]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
50.  Bryniarski P, Paradysz A, Zyczkowski M, Kupilas A, Nowakowski K, Bogacki R. A randomized controlled study to analyze the safety and efficacy of percutaneous nephrolithotripsy and retrograde intrarenal surgery in the management of renal stones more than 2 cm in diameter. J Endourol. 2012;26:52-57.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 89]  [Cited by in F6Publishing: 105]  [Article Influence: 8.1]  [Reference Citation Analysis (0)]
51.  Breda A, Angerri O. Retrograde intrarenal surgery for kidney stones larger than 2.5  cm. Curr Opin Urol. 2014;24:179-183.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 50]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
52.  Aboumarzouk OM, Monga M, Kata SG, Traxer O, Somani BK. Flexible ureteroscopy and laser lithotripsy for stones > 2 cm: a systematic review and meta-analysis. J Endourol. 2012;26:1257-1263.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 139]  [Cited by in F6Publishing: 147]  [Article Influence: 12.3]  [Reference Citation Analysis (0)]
53.  Hyams ES, Shah O. Percutaneous nephrostolithotomy versus flexible ureteroscopy/holmium laser lithotripsy: cost and outcome analysis. J Urol. 2009;182:1012-1017.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 73]  [Article Influence: 4.9]  [Reference Citation Analysis (0)]
54.  Miernik A, Schoenthaler M, Wilhelm K, Wetterauer U, Zyczkowski M, Paradysz A, Bryniarski P. Combined semirigid and flexible ureterorenoscopy via a large ureteral access sheath for kidney stones >2 cm: a bicentric prospective assessment. World J Urol. 2013;32:697-702.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 26]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
55.  Patel A. Lower Calyceal Occlusion by Autologous Blood Clot to Prevent Stone Fragment Reaccumulation after Retrograde Intra-Renal Surgery for Lower Calyceal Stones: First Experience of a New Technique. J Endourol. 2008;22:2501-2506.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 7]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
56.  Prabhakar M. Retrograde ureteroscopic intrarenal surgery for large (1.6-3.5 cm) upper ureteric/renal calculus. Indian J Urol. 2010;26:46-49.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 23]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
57.  Park J, Hong B, Park T, Park HK. Effectiveness of noncontrast computed tomography in evaluation of residual stones after percutaneous nephrolithotomy. J Endourol. 2007;21:684-687.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 70]  [Cited by in F6Publishing: 78]  [Article Influence: 4.6]  [Reference Citation Analysis (0)]
58.  Miller OF, Rineer SK, Reichard SR, Buckley RG, Donovan MS, Graham IR, Goff WB, Kane CJ. Prospective comparison of unenhanced spiral computed tomography and intravenous urogram in the evaluation of acute flank pain. Urology. 1998;52:982-987.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 169]  [Cited by in F6Publishing: 145]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
59.  Middleton WD, Dodds WJ, Lawson TL, Foley WD. Renal calculi: sensitivity for detection with US. Radiology. 1988;167:239-244.  [PubMed]  [DOI]  [Cited in This Article: ]
60.  Kennish SJ, Bhatnagar P, Wah TM, Bush S, Irving HC. Is the KUB radiograph redundant for investigating acute ureteric colic in the non-contrast enhanced computed tomography era? Clin Radiol. 2008;63:1131-1135.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 27]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]